Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lewy body dementia.

G Lennox1

  • 1University of Nottingham Medical School, UK.

Bailliere'S Clinical Neurology
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Lewy body dementia (LBD) is a common condition presenting with cognitive and psychiatric issues, often followed by parkinsonism. Early recognition and understanding its molecular basis are key for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Azathioprine prescribing in neurology.

Journal of neurology·2008
Same author

Lack of a pharmacokinetic interaction at steady state between ropinirole and L-dopa in patients with Parkinson's disease.

Pharmacotherapy·1999
Same author

Direct magnetic resonance imaging of carotid artery thrombus in acute stroke.

Lancet (London, England)·1999
Same author

Motor neurone disease-inclusion dementia.

Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration·1996
Same author

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Neurology·1996
Same author

Hypothermia due to hypothalamic involvement in multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·1996
Same journal

Remyelination in demyelinating disease.

Bailliere's clinical neurology·1999
Same journal

Other immunomodulatory therapies in multiple sclerosis.

Bailliere's clinical neurology·1999
Same journal

Copolymer-1.

Bailliere's clinical neurology·1999
Same journal

Interferon beta 1a.

Bailliere's clinical neurology·1999
Same journal

Treatment of multiple sclerosis with interferon beta 1b.

Bailliere's clinical neurology·1999
Same journal

The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis.

Bailliere's clinical neurology·1999
See all related articles

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Lewy body dementia (LBD) is a prevalent neurodegenerative disorder.
  • LBD presents with cognitive impairment, neuropsychiatric disturbances, and parkinsonism, or complicates Parkinson's disease.
  • It shares features with Alzheimer's disease but has distinct pathological and clinical characteristics.

Purpose of the Study:

  • To highlight the diagnostic challenges and clinical features of Lewy body dementia.
  • To discuss the potential for symptomatic management and future therapeutic targets.
  • To emphasize the need for understanding the molecular etiology of LBD.

Main Methods:

  • Review of clinical presentations and pathological findings in Lewy body dementia.
  • Comparison of LBD with Alzheimer's disease and Parkinson's disease.

Related Experiment Videos

  • Discussion of current therapeutic approaches and future research directions.

    • Main Results:

    • Lewy body dementia is recognizable during life, despite overlapping symptoms with other neurodegenerative diseases.
    • Some LBD manifestations can be managed with existing treatments.
    • Pathological and neurochemical features of LBD offer hope for palliative therapies.

    Conclusions:

    • Improved understanding of LBD's molecular mechanisms is crucial for developing effective treatments.
    • Early diagnosis and targeted therapies can improve patient outcomes.
    • Further research into LBD etiology is warranted for significant therapeutic progress.